Several women who have reported improvements in symptoms of polycystic ovary syndrome, a common hormonal disorder, after using GLP-1s such as Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. Patients and some health experts view GLP-1s as a promising potential option for a condition that lacks a standard treatment and affects millions of women in the U.S. But the drugs are not approved for that purpose, and much more research is needed to understand why they may help alleviate PCOS symptoms, such as irregular and painful periods. Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images
For well over a decade, Grace Hamilton, 27, experienced hair loss, heavy periods, infrequent menstrual cycles, mental health issues and difficulty losing weight without knowing why. It wasn’t until 2021